Thrupp, L, et al.
SHEA Long-Term-Care Committee. Tuberculosis prevention and control in long-term-care facilities for older adults. Infection Control & Hospital Epidemiology
2004; 25: 1097–1108.
Hochberg, NS, Horsburgh, CR Jr.
Prevention of tuberculosis in older adults in the United States: obstacles and opportunities. Clinical Infectious Diseases
2013; 56: 1240–1247.
Pratt, RH, et al.
Tuberculosis in older adults in the United States, 1993–2008. Journal of the American Geriatrics Society
2011; 59: 851–857.
Yoshikawa, TT. Important infections in elderly persons. Western Journal of Medicine
1981; 135: 441–445.
Rajagopalan, S. Tuberculosis and aging: a global health problem. Clinical Infectious Diseases
2001; 33: 1034–1039.
Rajagopalan, S, Yoshikawa, TT. Tuberculosis in long-term-care facilities. Infection Control & Hospital Epidemiology
2000; 21: 611–615.
Pai, M, Zwerling, A, Menzies, D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Annals of Internal Medicine
2008; 149: 177–184.
Diel, R, Loddenkemper, R, Nienhaus, A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest
2010; 137: 952–968.
Diel, R, et al.
Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. European Respiratory Journal
2011; 37: 88–99.
Fountain, FF, et al.
Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic. Chest
2005; 128: 116–123.
International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bulletin of the World Health Organization
1982; 60: 555–564.
Horsburgh, CR Jr., et al.
Revisiting rates of reactivation tuberculosis: a population-based approach. American Journal of Respiratory and Critical Care Medicine
2010; 182: 420–425.
Horsburgh, CR Jr., et al.
Tuberculosis Epidemiologic Studies Consortium. Latent TB infection treatment acceptance and completion in the United States and Canada. Chest
2010; 137: 401–409.
Wang, CS, et al.
The impact of age on the demographic, clinical, radiographic characteristics and treatment outcomes of pulmonary tuberculosis patients in Taiwan. Infection
2008; 36: 335–340.
Verma, G, Chuck, AW, Jacobs, P. Tuberculosis screening for long-term care: a cost-effectiveness analysis. International Journal of Tuberculosis and Lung Disease
2013; 17: 1170–1177.
Tuberculosis Surveillance Center; RIT; JATA. Tuberculosis annual report 2012 – (4) Tuberculosis treatment and outcomes [in Japanese]. Kekkaku
2014; 89: 825–834.
Katsenos, S, et al.
Use of interferon-gamma release assay for latent tuberculosis infection screening in older adults exposed to tuberculosis in a nursing home. Journal of the American Geriatrics Society
2011; 59: 858–862.
Ormerod, LP. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. British Medical Bulletin
2005; 73–74: 17–24.
Lobue, P, Menzies, D. Treatment of latent tuberculosis infection: an update. Respirology
2010; 15: 603–22.
Horsburgh, CR. Jr.
Priorities for the treatment of latent tuberculosis infection in the United States. New England Journal of Medicine
2004; 350: 2060–2067.
Sester, M, et al.
Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. European Respiratory Journal
2011; 37: 100–111.
Kowada, A. Cost effectiveness of the interferon-γ release assay for tuberculosis screening of hemodialysis patients. Nephrolgy Dialysis Transplantation
2013; 28: 682–688.
Kowada, A. Cost effectiveness of interferon-γ release assay for TB screening of HIV positive pregnant women in low TB incidence countries. Journal of Infection
2014; 68: 32–42.
Dobler, CC, Flack, JR, Marks, GB. Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study. British Medical Journal Open
Faurholt-Jepsen, D, et al.
Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls. Scandinavian Journal of Infectious Diseases
2014; 46: 384–391.
Tattevin, P, et al.
The validity of medical history, classic symptoms, and chest radiographs in predicting pulmonary tuberculosis: derivation of a pulmonary tuberculosis prediction model. Chest
1999; 115: 1248–1253.
Igakutsushin-sya. National fee schedule and Medical insurance reimbursement table in Japan [in Japanese]. Tokyo: Igakutsushin-sya, 2010.
World Health Organization. Guidelines on the Management of Latent Tuberculosis Infection. Geneva, World Health Organization, 2015.
Guo, N, Marra, F, Marra, CA. Measuring health-related quality of life in tuberculosis: a systematic review. Health and Quality of Life Outcomes
2009; 7: 14.
Dion, MJ, et al.
Feasibility and reliability of health-related quality of life measurements among tuberculosis patients. Quality of Life Research
2004; 13: 653–665.
Ijaz, K, et al.
Unrecognized tuberculosis in a nursing home causing death with spread of tuberculosis to the community. Journal of the American Geriatrics Society
2002; 50: 1213–1218.
Chitnis, AS, et al.
Trends in tuberculosis cases among nursing home residents, California, 2000 to 2009. Journal of the American Geriatrics Society
2015; 63: 1098–1104.
Kowada, A, et al.
Cost effectiveness of interferon-gamma release assay versus chest X-ray for tuberculosis screening of BCG-vaccinated elderly populations. Molecular Diagnosis & Therapy
2010; 14: 229–236.